Quantum Pharmaceuticals » druglikeness http://q-pharm.com The drug discovery company Thu, 05 Aug 2010 15:05:38 +0000 en hourly 1 http://wordpress.org/?v=3.0.1 Does size matter? http://q-pharm.com/2010/04/does-size-matter/ http://q-pharm.com/2010/04/does-size-matter/#comments Fri, 23 Apr 2010 09:37:58 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=220
  • Do we need those nM-inhibitors?
  • How drug-like are vendor libraries?
  • Protein Flexibility and False Positives detection.
  • Does hERG binding correlate with LogP?
  • How good are biological data – II: Trombine, GSK, GPCR
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2010/04/does-size-matter/feed/ 1     Do we need those nM-inhibitors? http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/ http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/#comments Wed, 11 Nov 2009 13:46:28 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=122
  • From Biological Spectra (multiple protein binding data) to pharmacological profiling!
  • Does size matter?
  • LD50 vs. MRDD: what’s death for a mice is good enough for a man
  • Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?
  • How drug-like are vendor libraries?
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/feed/ 1     How drug-like are vendor libraries? http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/ http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/#comments Mon, 26 Oct 2009 17:24:24 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=63
  • Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?
  • Computer aided drug design video from Quantum Pharma
  • From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2009/10/how-drug-like-are-vendor-libraries/feed/ 0     Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness? http://q-pharm.com/2008/01/drug-likeness-what-do-bioavailability-and-toxicity-properties-tell-us-about-druglikeness/ http://q-pharm.com/2008/01/drug-likeness-what-do-bioavailability-and-toxicity-properties-tell-us-about-druglikeness/#comments Wed, 09 Jan 2008 10:37:00 +0000 fedichev http://q-pharm.com/?p=21
  • Do we need those nM-inhibitors?
  • q-hERG: QUANTUM’s innovative approach to hERG binding calculations is finally released
  • How drug-like are vendor libraries?
  • Does size matter?
  • LD50 vs. MRDD: what’s death for a mice is good enough for a man
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2008/01/drug-likeness-what-do-bioavailability-and-toxicity-properties-tell-us-about-druglikeness/feed/ 0